Probes For Detection Of Specific Nucleotide Sequences Or Primers For The Synthesis Of Dna Or Rna Patents (Class 536/24.3)
-
Patent number: 8748094Abstract: This invention generally relates to particle-assisted nucleic acid sequencing. In some embodiments, sequencing may be performed in a microfluidic device, which can offer desirable properties, for example, minimal use of reagents, facile scale-up, and/or high throughput. In one embodiment, a target nucleic acid may be exposed to particles having nucleic acid probes. By determining the binding of the particles to the target nucleic acid, the sequence of the target nucleic acid (or at least a portion of the target nucleic acid) can be determined. The target nucleic acid may be encapsulated within a fluidic droplet with the particles having nucleic acid probes, in certain instances. In some cases, the sequence of the target nucleic acid may be determined, based on binding of the particles, using sequencing by hybridization (SBH) algorithms or other known techniques.Type: GrantFiled: December 18, 2009Date of Patent: June 10, 2014Assignee: President and Fellows of Harvard CollegeInventors: David A. Weitz, Adam R. Abate
-
Patent number: 8748095Abstract: The present invention provides a polymorphism detection probe that can identify a polymorphism in an EGFR gene easily and with high reliability and a polymorphism detection method using the probe. The probe of the present invention is a probe for detecting a polymorphism in an EGFR gene, including at least one of an oligonucleotide (P1) and an oligonucleotide (P2), wherein: (P1) is a 22- to 50-mer oligonucleotide composed of a base sequence complementary to a base sequence including 334th to 355th bases in SEQ ID NO: 1 and having a base complementary to the 334th base in its 3? end region; and (P2) is an oligonucleotide composed of a base sequence complementary to the oligonucleotide (P1).Type: GrantFiled: October 29, 2010Date of Patent: June 10, 2014Assignee: ARKRAY, Inc.Inventor: Moeko Ijuin
-
Patent number: 8741869Abstract: A substantially pure or isolated oligodeoxynucleotide of at least 10 nucleotides is disclosed, wherein the oligodeoxynucleotide comprised a sequence represented by either formula: 5? N1N2N3T-CpG-WN4N5N6 3? wherein the CpG motif is unmethylated, W is A or T, and N1, N2, N3, N4, N5, and N6 are nucleotides, or the formula: 5? RY-CpG-RY 3? wherein the central CpG motif is unmethylated, R is A or G, and Y is C or T, as well as an oligodeoxynucleotide delivery complex and a pharmacological composition comprising the present inventive oligodeoxynucleotide, and a method of inducing an immune response by administering the present inventive oligodeoxynucleotide to a host. In some embodiments, the oligodeoxynucleotide includes the nucleic acid sequences set forth as SEQ ID NO: 137.Type: GrantFiled: February 5, 2013Date of Patent: June 3, 2014Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, Uniformed Services University of the Health Sciences, an institution of higher learning within the Department of DefenseInventors: Dennis M. Klinman, Ken J. Ishii, Daniela Verthelyi, James J. Mond
-
Patent number: 8742084Abstract: This invention relates to agents and conjugates that can be used to detect and isolate target components from complex mixtures such as nucleic acids from biological samples, cells from bodily fluids, and nascent proteins from translation reactions. The invention also relates to targets isolated with conjugates which may be useful as pharmaceutical agents or compositions that can be administered to humans and other mammals. The invention further relates to kits comprised of agents and conjugates that can be used for the detection of diseases, disorders and individual substances in a complex background of substances.Type: GrantFiled: September 14, 2012Date of Patent: June 3, 2014Assignee: The Trustees of Boston UniversityInventors: Kenneth J. Rothschild, Sanjay M. Sonar, Jerzy Olejnik
-
Patent number: 8742083Abstract: MicroRNAs (miRNAs) that sensitize cancer cells to Bcl-2 family protein inhibitors are identified and described. Oligonucleotide panels, arrays and methods using the sensitizing miRNAs are also disclosed.Type: GrantFiled: December 23, 2010Date of Patent: June 3, 2014Assignee: AbbVie Inc.Inventors: Dimitri Semizarov, Xin Lu, Lloyd T. Lam
-
Patent number: 8741606Abstract: Aspects of the present invention include methods and compositions for determining the number of individual polynucleotide molecules originating from the same genomic region of the same original sample that have been sequenced in a particular sequence analysis configuration or process. In these aspects of the invention, a degenerate base region (DBR) is attached to the starting polynucleotide molecules that are subsequently sequenced (e.g., after certain process steps are performed, e.g., amplification and/or enrichment). The number of different DBR sequences present in a sequencing run can be used to determine/estimate the number of different starting polynucleotides that have been sequenced. DBRs can be used to enhance numerous different nucleic acid sequence analysis applications, including allowing higher confidence allele call determinations in genotyping applications.Type: GrantFiled: March 29, 2013Date of Patent: June 3, 2014Assignee: Population Genetics Technologies Ltd.Inventors: James Casbon, Sydney Brenner, Robert Osborne, Conrad Lichtenstein, Andreas Claas
-
Patent number: 8741560Abstract: The present invention is directed to compositions comprising mixtures of reagents, including thermostable enzymes (e.g., thermostable DNA polymerases), buffers, cofactors and other components, suitable for immediate use in nucleic acid amplification or sequencing techniques without dilution or addition of further components. The compositions contain no stabilizing agents (e.g., glycerol or serum albumin) and unexpectedly maintain activity for extended periods of time upon storage at temperatures above freezing. These compositions are useful, alone or in the form of kits, for nucleic acid amplification (e.g., by the Polymerase Chain Reaction) and sequencing (e.g., by dideoxy or “Sanger” sequencing), or for any procedure utilizing thermostable DNA polymerases in a variety of medical, forensic and agricultural applications. In particular, the compositions and methods are useful for amplifying and sequencing nucleic acid molecules that are larger than about 7 kilobases in size.Type: GrantFiled: January 6, 2012Date of Patent: June 3, 2014Assignee: Life Technologies CorporationInventors: Ayoub Rashtchian, Joseph Solus
-
Patent number: 8741565Abstract: A method for detecting a target nucleic acid of a pathogen in a test sample, the method comprising preparing a target nucleic acid detecting reagent and contacting the target nucleic acid detecting reagent with an oligonucleotide microarray. A kit for detecting a target nucleic acid of a pathogen in a test sample is also described. The kit comprises at least one primer pair and an oligonucleotide microarray comprising at least one probe.Type: GrantFiled: December 28, 2006Date of Patent: June 3, 2014Assignee: Honeywell International Inc.Inventors: Yuandong Gu, Leon Xu
-
Publication number: 20140147845Abstract: The present teachings relate to methods, compositions, and kits for detecting one or more target polynucleotide sequences in a sample, and methods compositions and kits for forming concatameric ligation products. In some embodiments of the present teachings, oligonucleotides are hybridized to complementary target polynucleotides and are ligated together to form a concatameric ligation product. In some embodiments of the present teachings, the concatameric ligation product can be amplified, and the identity and quantity of the target polynucleotides determined based on sequence introduced in the ligation reaction. Some embodiments of the present teachings provide methods for removing unligated probes from the reaction mixture. Some embodiments of the present teachings provide for highly multiplexed detection, identification, and quantification of a plurality of target polynucleotides using a variety of analytical procedures.Type: ApplicationFiled: October 24, 2013Publication date: May 29, 2014Applicant: APPLIED BIOSYSTEMS, LLCInventors: Caifu CHEN, Kevin HENNESSY, Kai LAO, Teodoro PANER, Vinod MIRCHANDANI
-
Patent number: 8735564Abstract: The present invention comprises a method that provides fast and reliable results for detecting the presence of a target nucleic acid molecule in a sample.Type: GrantFiled: September 14, 2012Date of Patent: May 27, 2014Assignee: Qiagen Gaithersburg, Inc.Inventors: Paul Eder, Eric Payne, Irina Nazarenko, Suganthi Ramachandran, Arvind Virmani, Laura Bell
-
Patent number: 8735060Abstract: The invention relates to a purification method for high-purity, DNA-free RNA using a mixture of nanocarrier beads and paramagnetic beads.Type: GrantFiled: July 29, 2010Date of Patent: May 27, 2014Assignee: Stratec Molecular AGInventor: Hans Joos
-
Patent number: 8735072Abstract: Methods of screening candidate agents to identify lead compounds for the development of therapeutic agents for the treatment of a neurodegenerative disease, such as Huntington's Disease and Parkinson's Disease and methods for identifying a mutation in, or changes in expression of, a gene associated with neurodegenerative disease, such as Huntington's Disease and Parkinson's Disease, are provided.Type: GrantFiled: March 13, 2012Date of Patent: May 27, 2014Assignees: Whitehead Institute for Biomedical Research, University of WashingtonInventors: Paul J. Muchowski, Susan L. Lindquist, Tiago Outeiro
-
Patent number: 8735058Abstract: The present invention relates to certain novel shRNA molecules and methods of use thereof. According to certain embodiments of the present invention, methods for reducing the expression level of a target gene are provided. Such methods generally comprise providing a cell with one or more precursor nucleic acid sequences that encode two or more RNA molecules. A first RNA molecule comprises a double stranded sequence, which includes a guide strand sequence that is complementary to a portion of an mRNA transcript encoded by the target gene. In addition, a second RNA molecule comprises a second double stranded sequence, which includes a second guide strand sequence that is partially complementary to a portion of the mRNA transcript encoded by the target gene. Preferably, the second guide strand sequence comprises one or more bases that are mismatched with a nucleic acid sequence of the mRNA transcript encoded by the target gene.Type: GrantFiled: June 29, 2012Date of Patent: May 27, 2014Assignee: Gradalis, Inc.Inventor: Donald Rao
-
Patent number: 8735661Abstract: The invention provides cotton event MON 88701, and plants, plant cells, seeds, plant parts, and commodity products comprising event MON 88701. The invention also provides polynucleotides specific for event MON 88701 and plants, plant cells, seeds, plant parts, and commodity products comprising polynucleotides specific for event MON 88701. The invention also provides methods related to event MON 88701.Type: GrantFiled: March 13, 2012Date of Patent: May 27, 2014Assignee: Monsanto Technology LLCInventors: Ronald J. Brinker, Wen C. Burns, Paul C. C. Feng, John A. Kendig, Sherry LeClere, Jennifer Lutke, Marianne Malven
-
Patent number: 8735063Abstract: The present invention is directed to methods and reagents for determining the genotype of a hepatitis C virus (HCV) species present in a test sample. The invention more particularly relates to mixtures of degenerate amplification and sequencing primers, and methods of using such primers, that are complementary to a plurality of HCV species, and are capable of generating nucleotide sequence information for a region of NS5B of HCV that is, for each species, indicative of the type and/or subtype, of the species present in the sample.Type: GrantFiled: October 30, 2009Date of Patent: May 27, 2014Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Marcellinus Beld, Remko Gouw, Toumy Guettouche, James Hnatyszyn, Carola van der Meer
-
Publication number: 20140141418Abstract: Provided is a dual-hybridization polynucleotide including a first complementary region that is complementary to the 3?-terminus of a target nucleic and a second complementary region that is complementary to the 5?-terminus of the target nucleic acid, a composition and kit including the polynucleotide, and a method of producing a nucleotide sequence complementary to the target nucleic acid. The first complementary region to be bound at the 3?-terminus of the target nucleic acid can be shortened and the target nucleic acid may be amplified with excellent specificity and/or sensitivity.Type: ApplicationFiled: May 21, 2013Publication date: May 22, 2014Inventors: Dong-hyun PARK, Sung-woo HONG, Kyung-hee PARK, Myo-yong LEE
-
Patent number: 8729251Abstract: The present invention provides massively parallel oligonucleotide synthesis and purification for applications that utilize large collections of defined high-fidelity oligonucleotides (e.g., from about 101 to about 105 different sequences, generally between 25-160 bases in length).Type: GrantFiled: November 20, 2012Date of Patent: May 20, 2014Assignee: Affymetrix, Inc.Inventors: Robert G. Kuimelis, Glenn H. McGall
-
Patent number: 8728766Abstract: Aspects of the present invention include methods and compositions for determining the number of individual polynucleotide molecules originating from the same genomic region of the same original sample that have been sequenced in a particular sequence analysis configuration or process. In these aspects of the invention, a degenerate base region (DBR) is attached to the starting polynucleotide molecules that are subsequently sequenced (e.g., after certain process steps are performed, e.g., amplification and/or enrichment). The number of different DBR sequences present in a sequencing run can be used to determine/estimate the number of different starting polynucleotides that have been sequenced. DBRs can be used to enhance numerous different nucleic acid sequence analysis applications, including allowing higher confidence allele call determinations in genotyping applications.Type: GrantFiled: March 29, 2013Date of Patent: May 20, 2014Assignee: Population Genetics Technologies Ltd.Inventors: James Casbon, Sydney Brenner, Robert Osborne, Conrad Lichtenstein, Andreas Claas
-
Patent number: 8729025Abstract: This invention relates to methods for altering the splicing of mRNA in cells. In particular, this invention also relates to methods for increasing the ratio of wild type to misspliced forms of mRNA and corresponding encoded proteins in cells possessing a mutant gene encoding either the i) misspliced mRNA corresponding to the mutant protein or ii) a component in the splicing machinery responsible for processing the misspliced mRNA. In addition, this invention relates to treating individuals having a disorder associated with a misspliced mRNA, such as Familial Dysautonomia or Neurofibromatosis 1, by administering to such an individual a cytokinin such as kinetin.Type: GrantFiled: August 31, 2012Date of Patent: May 20, 2014Assignee: The General Hospital CorporationInventors: Susan A. Slaugenhaupt, James F. Gusella
-
Patent number: 8728736Abstract: The present invention provides methods, compositions, kits, systems and apparatus that are useful for multiplex PCR of one or more nucleic acids present in a sample. In particular, various target-specific primers are provided that allow for the selective amplification of one or more target sequences. In one aspect, the invention relates to target-specific primers useful for the selective amplification of one or more target sequences associated with cancer or inherited disease. In some aspects, amplified target sequences obtained using the disclosed methods, kits, systems and apparatuses can be used in various downstream processes including nucleic acid sequencing and used to detect the presence of genetic variants.Type: GrantFiled: September 14, 2012Date of Patent: May 20, 2014Assignee: Life Technologies CorporationInventors: John Leamon, Mark Andersen, Michael Thornton
-
Patent number: 8728727Abstract: The invention relates to an ex vivo method of diagnosing or predicting an hereditary spastic paraplegias (HSP), in a subject, which method comprises detecting a mutation in the KIAA1840 gene or protein (spatacsin), wherein said mutation is indicative of an hereditary spastic paraplegias (HSP).Type: GrantFiled: August 6, 2012Date of Patent: May 20, 2014Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)Inventors: Hamid Azzedine, Alexis Brice, Giovanni Stevanin, Filippo Santorelli, Paola Denora
-
Patent number: 8729046Abstract: Methods are provided for treating fibrosis of a tissue, including fibrosis of the liver, using combinations of antagomirs and/or locked nucleic acids. Compositions therefor are also provided.Type: GrantFiled: December 6, 2012Date of Patent: May 20, 2014Assignee: Albert Einstein College of Medicine of Yeshiva UniversityInventors: Leslie E. Rogler, Charles E. Rogler
-
Patent number: 8728728Abstract: The present invention provides methods, compositions, kits, systems and apparatus that are useful for multiplex PCR of one or more nucleic acids present in a sample. In particular, various target-specific primers are provided that allow for the selective amplification of one or more target sequences. In one aspect, the invention relates to target-specific primers useful for the selective amplification of one or more target sequences associated with cancer or inherited disease. In some aspects, amplified target sequences obtained using the disclosed methods, kits, systems and apparatuses can be used in various downstream processes including nucleic acid sequencing and used to detect the presence of genetic variants.Type: GrantFiled: September 14, 2012Date of Patent: May 20, 2014Assignee: Life Technologies CorporationInventors: John Leamon, Mark Andersen, Michael Thornton
-
Publication number: 20140137296Abstract: The present invention relates to a transcription factor gene that plays a key role in Solanaceae fruit ripening. Plants overexpressing the gene have fruits with deeper pigmentation and ripen more rapidly than controls. The invention also relates to transgenic plants comprising said gene, and methods of making said plants.Type: ApplicationFiled: September 27, 2011Publication date: May 15, 2014Applicant: SYNGENTA PARTICIPATIONS AGInventors: Charles Baxter, Yu Pan, Charlie Hodgman, Graham Barron Seymour, Rebecca Cade, Henricus Johannes Van Wijk, Glyn Bradely, Laurent Grivet, Laurie Boyden, Graham Ball, Paul Fraser
-
Patent number: 8722583Abstract: Disclosed is a method for determining the identity of a chemical entity having a preselected property. The chemical entity is identified from a library composed of a plurality of different chemical entities each appended to unique identifier tags. An anti-tag having the capability of specifically interacting with the unique identifier tag is recovered during the method and used for identification purposes.Type: GrantFiled: April 13, 2006Date of Patent: May 13, 2014Assignee: Nuevolution A/SInventors: Alex Haahr Gouliaev, Thomas Franch
-
Patent number: 8722865Abstract: Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human and tumor suppressing subtransferable candidate 4 (TSSC4) and methods of use.Type: GrantFiled: September 24, 2011Date of Patent: May 13, 2014Inventor: James Ryan
-
Patent number: 8722368Abstract: Aspects of the present invention include methods and compositions for determining the number of individual polynucleotide molecules originating from the same genomic region of the same original sample that have been sequenced in a particular sequence analysis configuration or process. In these aspects of the invention, a degenerate base region (DBR) is attached to the starting polynucleotide molecules that are subsequently sequenced (e.g., after certain process steps are performed, e.g., amplification and/or enrichment). The number of different DBR sequences present in a sequencing run can be used to determine/estimate the number of different starting polynucleotides that have been sequenced. DBRs can be used to enhance numerous different nucleic acid sequence analysis applications, including allowing higher confidence allele call determinations in genotyping applications.Type: GrantFiled: March 29, 2013Date of Patent: May 13, 2014Assignee: Population Genetics Technologies Ltd.Inventors: James Casbon, Sydney Brenner, Robert Osborne, Conrad Lichtenstein, Andreas Claas
-
Patent number: 8716457Abstract: The present invention provides modified nucleobase compounds, modified nucleic acid mimetic compounds and various uses thereof. In addition, the invention provides methods for nucleobase characterisation, SNP characterisation and nucleic acid sequencing.Type: GrantFiled: September 19, 2008Date of Patent: May 6, 2014Assignee: The University Court of the University of EdinburghInventors: Mark Bradley, Juan J. Diaz-Mochon
-
Patent number: 8715927Abstract: Disclosed herein is the identification of human DNA polymerase ? (pol ?) as the polymerase that mediates repair of DNA containing interstrand cros slinks (ICLs). The mechanism of action of a number of chemotherapeutic and antimicrobial agents is the induction of ICLs. Thus, provided herein is a method of enhancing the efficacy of a chemotherapeutic or antimicrobial agent in a subject, including selecting a subject in need of treatment with an ICL -inducing agent and administering to the subject an ICL-inducing agent and a therapeutically effective amount of an inhibitor of pol ?. Also provided is a composition for treating a hyperproliferative disease, an autoimmune disease or an infectious disease, comprising an ICL-inducing agent and an amount of an inhibitor of pol ? sufficient to enhance the efficacy of the ICL-inducing agent. Further provided is a method of identifying a DNA polymerase inhibitor.Type: GrantFiled: April 22, 2009Date of Patent: May 6, 2014Assignee: Oregon Health & Science UniversityInventors: R. Stephen Lloyd, Irina G. Minko, Amanda K. McCullough
-
Patent number: 8715967Abstract: Aspects of the present invention include methods and compositions for determining the number of individual polynucleotide molecules originating from the same genomic region of the same original sample that have been sequenced in a particular sequence analysis configuration or process. In these aspects of the invention, a degenerate base region (DBR) is attached to the starting polynucleotide molecules that are subsequently sequenced (e.g., after certain process steps are performed, e.g., amplification and/or enrichment). The number of different DBR sequences present in a sequencing run can be used to determine/estimate the number of different starting polynucleotides that have been sequenced. DBRs can be used to enhance numerous different nucleic acid sequence analysis applications, including allowing higher confidence allele call determinations in genotyping applications.Type: GrantFiled: March 29, 2013Date of Patent: May 6, 2014Assignee: Population Genetics Technologies Ltd.Inventors: James Casbon, Sydney Brenner, Robert Osborne, Conrad Lichtenstein, Andreas Claas
-
Publication number: 20140120629Abstract: Provided are nucleic acid structures suitable for reproducible Raman spectroscopy, methods of preparing the same, and methods of detecting a target material using the nucleic acid structures, whereby various target materials may be analyzed by using reproducible Raman spectroscopy.Type: ApplicationFiled: October 30, 2013Publication date: May 1, 2014Applicant: Samsung Electronics Co., Ltd.Inventors: Myoung-soon KIM, Jong-myeon Park, Jung-won Keum, Chang-eun Yoo
-
Patent number: 8709788Abstract: Characteristics of a chemical or biological sample are detected using an approach involving light detection. According to an example embodiment of the present invention, an assaying arrangement including a light detector is adapted to detect light from a sample, such as a biological material. A signal corresponding to the detected light is used to characterize the sample, for example, by detecting a light-related property thereof. In one implementation, the assaying arrangement includes integrated circuitry having a light detector and a programmable processor, with the light detector generating a signal corresponding to the light and sending the signal to the processor. The processor provides an output corresponding to the signal and indicative of a characteristic of the sample.Type: GrantFiled: November 19, 2012Date of Patent: April 29, 2014Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Abbas El Gamal, Helmy Eltoukhy, Khaled Salama
-
Patent number: 8709716Abstract: Arrays for genome-wide analysis of methylation are disclosed. IN a preferred aspect arrays comprising a plurality of probes complementary to a plurality of identified CpG islands in the human, mouse and rat genome are disclosed. The arrays may be used to detect methylation within cpG islands in samples from human, mouse and rat genomes.Type: GrantFiled: January 27, 2011Date of Patent: April 29, 2014Assignee: Affymetrix, Inc.Inventors: Yanxiang Cao, Shivani Nautiyal, Charles G. Miyada, Christopher Davies, Gangwu Mei, Alan J Williams, Eric B. Schell, John E. Blume
-
Patent number: 8709722Abstract: There is provided a method for detecting binding of a DNA-binding protein to a target recognition sequence. The method comprises mixing in a reaction buffer a first set of metal nanoparticles, a second set of metal nanoparticles and a DNA-binding protein to form a mixture, and detecting the aggregation state of the mixture of metal nanoparticles. Each set of metal nanoparticles has a conjugated double-stranded DNA molecule having a single-stranded overhang at one end. The single-stranded overhangs of each set of DNA-conjugated metal nanoparticles are complementary to each other such that annealing of the complementary overhangs results in formation of the target recognition sequence that specifically binds the DNA-binding protein. The reaction buffer comprises an ionic species in a concentration sufficient to result in aggregation of the metal nanoparticles upon annealing of the first and second single-stranded overhang.Type: GrantFiled: August 24, 2012Date of Patent: April 29, 2014Assignee: Agency for Science, Technology and ResearchInventors: Yen Nee Tan, Xiaodi Su
-
Patent number: 8709726Abstract: Provided herein are compositions, processes and kits for noninvasive, early determination of fetal sex from, and/or amount of fetal nucleic acid in, an extracellular nucleic acid sample from a pregnant female. Such compositions, processes and kits are useful for detection of low genomic copy numbers of male fetal nucleic acid in a high copy number background of female nucleic acid, thereby determining the sex of a fetus and/or amount of fetal nucleic acid in a sample.Type: GrantFiled: March 10, 2009Date of Patent: April 29, 2014Assignee: Sequenom, Inc.Inventors: Paul Andrew Oeth, Payam Mahboubi, Min Seob Lee
-
Patent number: 8709720Abstract: Disclosed herein is a method for identifying single nucleotide polymorphisms of a target nucleic acid for predicting whether a patient suffering from hepatocellular carcinoma will respond to a 5-fluorouracil (5-FU)-based combination chemotherapy. In some embodiments, biological sample derived from the patient is processed to determine the presence of a T/T genotype of rs9679162 GALNT14 gene. The presence of the above-identified genotype is an indication that the patient is responsive to the 5-FU-based combination chemotherapy.Type: GrantFiled: March 2, 2012Date of Patent: April 29, 2014Inventors: Chau-Ting Yeh, Kung-Hao Liang
-
Patent number: 8710208Abstract: The present teachings provide methods, compositions, and kits for quantifying target polynucleotides. In some embodiments, a reverse stem-loop ligation probe is ligated to the 3? end of a target polynucleotide, using a ligase that can ligate the 3? end of RNA to the 5? end of DNA using a DNA template, such as T4 DNA ligase. Following digestion to form an elongated target polynucleotide with a liberated end, a reverse transcription reaction can be performed, followed by a PCR. In some embodiments, the methods of the present teachings can discriminate between polymorphic polynucleotides that vary by as little as one nucleotide.Type: GrantFiled: April 26, 2012Date of Patent: April 29, 2014Assignee: Applied Biosystems, LLCInventors: Ruoying Tan, Caifu Chen, Karl J. Guegler
-
Publication number: 20140114048Abstract: Dark quencher constructs, termed “multi-chromophoric quenchers” are described herein that comprise at least two dark quenching moieties, which can be the same or different, linked together by at least one multivalent linking moiety. The structure of the multi-chromophoric quenchers can be varied to selectively enhance quenching within a specific range of reporter emission wavelengths, to quench a broader range of reporter emission wavelengths than previously possible, or can combine both concepts. Multiple types of quenching moieties can be employed to increase the absorption range and a multiple number of each type of quenching moiety can be used to increase the total absorptivity within the absorption range. The multi-chromophoric quenchers can be tethered to probes for biomolecules, insoluble supports and/or fluorescent dyes for use in a wide variety of biomolecular assays.Type: ApplicationFiled: October 15, 2013Publication date: April 24, 2014Applicant: Applied Biosystems, LLCInventors: Scott BENSON, Steven MENCHEN, Krishna UPADHYA
-
Patent number: 8703925Abstract: A chemically-enhanced primer is provided comprising a negatively charged moiety (NCM), an oligonucleotide sequence having a) non-nuclease resistant inter-nucleotide linkages or b) at least one nuclease resistance inter-nucleotide linkage. The chemically-enhanced primer can be used for sequencing and fragment analysis. Methods for synthesizing the chemically-enhanced primer as well as a method of preparing DNA for sequencing, a method of sequencing DNA, and kits containing the chemically-enhanced primer are also provided. The method of sequencing DNA can comprise contacting amplification reaction products with the composition wherein excess amplification primer is degraded by the nuclease and the chemically-enhanced primer is essentially non-degraded.Type: GrantFiled: February 15, 2012Date of Patent: April 22, 2014Assignee: Life Technologies CorporationInventors: Linda Lee, Sam Woo, Peter Ma
-
Patent number: 8703928Abstract: The present invention describes a method for identifying one or more of a plurality of sequences differing by one or more single base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences. The method includes a ligation phase, a capture phase, and a detection phase. The ligation phase utilizes a ligation detection reaction between one oligonucleotide probe, which has a target sequence-specific portion and an addressable array-specific portion, and a second oligonucleotide probe, having a target sequence-specific portion and a detectable label. After the ligation phase, the capture phase is carried out by hybridizing the ligated oligonucleotide probes to a solid support with an array of immobilized capture oligonucleotides at least some of which are complementary to the addressable array-specific portion. Following completion of the capture phase, a detection phase is carried out to detect the labels of ligated oligonucleotide probes hybridized to the solid support.Type: GrantFiled: September 9, 2011Date of Patent: April 22, 2014Assignee: Cornell Research Foundation, Inc.Inventors: Francis Barany, George Barany, Robert P. Hammer, Maria Kempe, Herman Blok, Monib Zirvi
-
Patent number: 8697859Abstract: The invention relates to isolated DNA or RNA molecules comprising at least ten contiguous bases having a sequence in a pancreatic islet microRNA. In another embodiment, the invention relates to isolated single stranded pancreatic islet microRNA molecules or anti-pancreatic islet microRNA molecules.Type: GrantFiled: January 18, 2013Date of Patent: April 15, 2014Assignee: The Rockefeller UniversityInventors: Markus Stoffel, Matthew N. Poy, Thomas H. Tuschl
-
Patent number: 8697356Abstract: A single-chain probe of the present invention for detecting a ligand, comprises: a ligand binding protein for binding the ligand; a recognition protein for recognizing that the ligand is bound by the ligand binding protein; and C- and N-terminal fragments, generated by dissecting an enzyme, between the ligand binding protein and the recognition protein, wherein a carboxy terminal end of the C-terminal fragment is located upstream of an amino terminal end of the N-terminal fragment, and the C- and N-terminal fragments vary the enzyme activity via complementation in case where the recognition protein recognizes that the ligand is bound by the ligand binding protein. This makes it possible to achieve detection of a target protein-specific ligand using the single chain with a high efficiency.Type: GrantFiled: April 24, 2009Date of Patent: April 15, 2014Assignee: National Institute of Advanced Industrial Science and TechnologyInventors: Sung-Bae Kim, Hiroaki Tao, Moritoshi Sato
-
Publication number: 20140100110Abstract: Compositions and methods related to transgenic high oleic acid/ALS inhibitor-tolerant soybean plants are provided. Specifically, the present invention provides soybean plants having a DP-305423-1 event which imparts a high oleic acid phenotype and tolerance to at least one ALS-inhibiting herbicide. The soybean plant harboring the DP-305423-1 event comprises genomic/transgene junctions having at least the polynucleotide sequence of SEQ ID NO:8, 9, 14, 15, 20, 21, 83 or 84. The characterization of the genomic insertion site of the DP-305423-1 event provides for an enhanced breeding efficiency and enables the use of molecular markers to track the transgene insert in the breeding populations and progeny thereof. Various methods and compositions for the identification, detection, and use of the soybean DP-305423-1 events are provided.Type: ApplicationFiled: October 14, 2013Publication date: April 10, 2014Applicant: E. I. DU PONT DE NEMOURS AND COMPANYInventors: Anthony J. KINNEY, Keven L. STECCA, Knut MEYER, Kent BRINK, Robert F. CRESSMAN, JR., Natalie N. WEBER, Cathy Xiaoyan ZHONG
-
Patent number: 8691509Abstract: In certain embodiments, the invention provides amplification methods in which nucleotide tag(s) and a barcode nucleotide sequence are added to target nucleotide sequences. In other embodiments, the present invention provides a microfluidic device that includes a plurality of first input lines and a plurality of second input lines. The microfluidic device also includes a plurality of sets of first chambers and a plurality of sets of second chambers. Each set of first chambers is in fluid communication with one of the plurality of first input lines. Each set of second chambers is in fluid communication with one of the plurality of second input lines. The microfluidic device further includes a plurality of first pump elements in fluid communication with a first portion of the plurality of second input lines and a plurality of second pump elements in fluid communication with a second portion of the plurality of second input lines.Type: GrantFiled: April 2, 2010Date of Patent: April 8, 2014Assignee: Fluidigm CorporationInventors: Andrew May, Peilin Chen, Jun Wang, Fiona Kaper, Megan Anderson
-
Patent number: 8691504Abstract: The present invention relates to a method and a kit for detecting nucleic acid sequence variation using melting curve analysis, especially relates to a method and a kit for detecting nucleic acid sequence variation by melting curve analysis using self-quenched probe. Said method provides the characteristics of the self-quenched probe employed, as well as the corresponding nucleic acid amplification conditions, so that the probe can bind to the amplified target sequence, and variations of the target sequence can be detected by melting curve analysis. The present invention also encompasses a kit assembled according to the method described.Type: GrantFiled: May 26, 2010Date of Patent: April 8, 2014Assignee: Xiamen UniversityInventors: Qingge Li, Qiuying Huang
-
Patent number: 8691508Abstract: Contemplated systems and methods allow analysis of multiple and distinct patient samples using a labeling scheme that entirely avoids carry-over of a label or reagent to the analytic platform, typically an addressable solid phase. In preferred aspects, a hybridization portion, a fluorophore, and/or a quencher are removed by a 5?-3?-exonuclease activity of a polymerase from a reporter oligonucleotide to so remove the oligonucleotide from the pool of molecules that bind to the solid phase and/or or to provide signal differentiation by removal of a fluorophore or quencher.Type: GrantFiled: December 13, 2007Date of Patent: April 8, 2014Assignee: Autogenomics, Inc.Inventor: Nanibhushan Dattagupta
-
Patent number: 8691505Abstract: The problem to be solved by the present invention is to provide a highly-efficient transformation technology, specifically, a highly-efficient promoter used for transforming algae, a vector comprising the promoter, and a method for transforming algae by using the vector. The promoter according to the present invention is characterized in comprising a polynucleotide constituting a non-coding region located upstream of a gene encoding a structural protein of a ClorDNA virus, and the like.Type: GrantFiled: February 10, 2011Date of Patent: April 8, 2014Assignee: Kochi UniversityInventors: Masao Adachi, Takuma Okami, Keizo Nagasaki, Yuji Tomaru
-
Patent number: 8691507Abstract: The invention relates to determining the presence of an EZH2 gene mutation in a sample from a subject and inhibition of wild-type and certain mutant forms of human histone methyltransferase EZH2, the catalytic subunit of the PRC2 complex which catalyzes the mono-through tri-methylation of lysine 27 on histone H3 (H3-K27). In one embodiment the inhibition is selective for the mutant form of the EZH2, such that trimethylation of H3-K27, which is associated with certain cancers, is inhibited. The methods can be used to treat cancers including follicular lymphoma and diffuse large B-cell lymphoma (DLBCL). Also provided are methods for identifying small molecule selective inhibitors of the mutant forms of EZH2 and also methods for determining responsiveness to an EZH2 inhibitor in a subject.Type: GrantFiled: July 23, 2013Date of Patent: April 8, 2014Assignee: Epizyme, Inc.Inventors: Robert A. Copeland, Victoria M. Richon, Margaret D. Scott, Christopher J. Sneeringer, Kevin W. Kuntz, Sarah K. Knutson, Roy M. Pollock
-
Patent number: 8685649Abstract: The invention relates to a reverse transcription loop-mediated isothermal amplification (LAMP) assay for the detection of dengue virus. The assay is capable of simultaneous detection of dengue 1-4 serotypes in a single reaction.Type: GrantFiled: June 9, 2011Date of Patent: April 1, 2014Assignee: The United States of America as represented by the Secretary of the NavyInventors: Allison Dauner, Subhamoy Pal, Shuenn-Jue Wu
-
Patent number: 8686230Abstract: The present invention provides a corn plant designated MON88017 and DNA compositions contained therein. Also provided are assays for detecting the presence of the corn plant MON88017 based on a DNA sequence and the use of this DNA sequence as a molecular marker in a DNA detection method.Type: GrantFiled: June 21, 2012Date of Patent: April 1, 2014Assignee: Monsanto Technology LLCInventors: Kim A. Beazley, Timothy R. Coombe, Mark E. Groth, Terri B. Hinchey, Jay C. Pershing, Ty T. Vaughn, Bei Zhang